Authors
Latest:
California Startup Exploring Novel ALS Discovery PlatformA grant from the National Institute of Neurological Disorders and Stroke, which allows for concurrent phase I and II trial design review, will speed up the development of novel treatments for patients with ALS and FTD.
Latest:
David Kemlink, MD, PhD: Actigraphic Recordings in Rapid Eye Movement Sleep Behavior DisorderActigraphic recording from upper extremities show consistently more prominent sleep fragmentation in rapid eye movement sleep behavior disorder patients compared to other sleep diagnoses.
Latest:
Page B. Pennell, MD: Improving Epilepsy Care in 2020 and BeyondThe president of the American Epilepsy Society and director of epilepsy research at Brigham and Women’s Hospital outlined the state of epilepsy care and what we can expect in 2020.
Latest:
Paul Durham, PhD: A Combination Approach With nVNS in MigraineThe distinguished professor and director of cell biology at Missouri State University discussed the use of nVNS in migraine treatment and whether or not it can replace the use of or be used in conjunction with triptans—a medication on which many patients fail or report poor response on.
Latest:
Video: Multisymptomatic Care in Parkinson's DiseaseStuart Isaacson, MD, Rajesh Pahwa, MD, and Jennifer Goldman, MD discuss optimizing PD treatment with levodopa and adjunct therapies, addressing patient and pharmacologic challenges, coordinating care, and anticipating the impact of emerging therapies and upcoming Medicare Part D changes.
Latest:
EEG Abnormalities in Acutely Ill Patients With COVID-19Preliminary findings from a retrospective sample series in the Bronx, New York.
Latest:
The Treatment of Status Migrainosus in Emergency Care Settings: Matthew Robbins, MDThe neurologist at Weill Cornell Medicine and NewYork-Presbyterian Hospital offered his insight into the state of treatment for status migrainosus and whether or not the new migraine medications can help improve care. [WATCH TIME: 2 minutes]
Latest:
Bryan Davis, PsyD, MS: Future Discussion on Masculinity Norms in MSThe clinical health psychology fellow at Cleveland Clinic’s Mellen Center for MS Treatment and Research at Cleveland Clinic details the interventions for men with MS and how the study can change the discussion on masculinity norms.
Latest:
Awareness Empowers Care for Patients With Parkinson DiseaseParkinson disease is neither imminently fatal nor transient but is incurable, and as it affects individuals differently based on their unique identities, culture, access to health care, and social support, it is vital to empower patients.
Latest:
EEG Abnormalities in Acutely Ill Patients With COVID-19Preliminary findings from a retrospective sample series in the Bronx, New York.
Latest:
Question and Answer about Neurofilament Light Chain and Other MS BiomarkersMark Freedman, MD, MSc, Tanuja Chitnis, MD, and Ahmed Obeidat, MD, PhD, answer questions about biomarkers in MS care.
Latest:
Unmet Needs in the Treatment of Spinal Muscular AtrophyA panel of experts considers current unmet needs in SMA by emphasizing the need for further study of combination therapy, more comprehensive newborn screening, and more effective early diagnosis and treatment.
Latest:
Alexander Kolevzon, MD: The STARS Study in Angelman SyndromeThe director of Child and Adolescent Psychiatry at Mount Sinai Health System spoke about the results of the phase 2 study of OV101 (gaboxadol), and the next steps for the phase 3 trial.
Latest:
Unraveling the Complexity of Fatigue in Multiple Sclerosis: John DeLuca, PhDThe senior vice president for Research and Training at Kessler Foundation talked about the issue of fatigue in patients with multiple sclerosis and the significant, multifaceted challenges patients face. [WATCH TIME: 5 minutes]
Latest:
Hillary Thomas, PhD: Screening Patients With Epilepsy for DepressionThe pediatric psychologist at Children’s Medical Center discussed what her team does to assess patients in the clinic when something comes up as a result of a patient’s screening.
Latest:
Dan Barber, MBA: Advantages of Diazepam Buccal Soluble Film FormulationThe SVP and chief strategy and development officer at Aquestive Therapeutics discussed the hope to provide both patients and providers with a more favorable, and still efficacious, option for seizure clusters.
Latest:
How Big Data Can Drive Advancements in MS ResearchBig data is on the precipice of revolutionizing multiple sclerosis knowledge and treatment.
Latest:
Bernd Feige, PhD: Insomnia and the REM Sleep StateThe study presents direct evidence that subjective experiences of insomnia may be coupled to the REM sleep state.
Latest:
Everyone Is Working Hard: Why Shift Work Shouldn't Be CelebratedDanielle B. Cross, MD, MS, a neurology resident in training, shares her thoughts on why glorifying exhaustion is unhealthy.
Latest:
Raising Awareness for Spinal Muscular Atrophy and Improving Newborn Screening: Crystal Proud, MDThe director of neurology and neuromuscular medicine at the Children’s Hospital of the King’s Daughters in Norfolk, Virginia, discussed SMA Awareness Month and the enhancements to newborn screening for the disease. [WATCH TIME: 4 minutes]
Latest:
Addressing Specific Social Determinants of Health in Epilepsy: Joseph Sirven, MDThe professor of neurology at Mayo Clinic detailed ways to address social determinants of health and the gaps in care for patients with epilepsy.
Latest:
Margaret Moline, PhD: Next-Morning Residual Effects of Lemborexant in InsomniaThe International Project Team Lead spoke about the results of study endpoints that assessed the potential for next-morning residual effects of lemborexant, which is in development for insomnia.
Latest:
Navigating Insurance and Access Issues in MigraineCurrent hurdles faced by neurologists when prescribing therapy to treat migraine and advice to help other healthcare professionals as well as patients navigate insurance and access issues.
Latest:
Importance of Multidisciplinary Care in Management of Neurofibromatosis Type 1 Related Plexiform NeurofibromaKaleb Yohay, MD, an expert in NF1-PN, emphasizes the importance of multidisciplinary and comprehensive team care in managing the condition, detailing the essential team members required to facilitate a successful transition from adolescent to adult care.
Latest:
Uri Kramer, MD: Treating Epilepsy With CannabisThe professor of pediatrics at Tel Aviv University explained what has been fleshed out by the research and shared his opinion on cannabidiol’s use.
Latest:
Researching Dravet Syndrome Biomarkers to Advance Treatment: Christos Papadelis, PhDThe director of research in the Jane and John Justin Neurosciences Center at Cook Children's Health Care System talked about ongoing research on biomarkers to enhance treatment and improve cognitive outcomes. [WATCH TIME: 6 minutes]
Latest:
Sarah Wilson, PhD: Long-Term Social Outcomes of Epilepsy SurgeryThe clinical neuropsychologist and head of the School of Psychological Sciences at the University of Melbourne discussed the results of a study she and colleagues conducted in which they mapped the long-term social outcomes of patient post-epilepsy surgery.
Latest:
Conversations With Patients About Mild/Moderate Multiple SclerosisThe expert panel examines early multiple sclerosis (MS) and patients with mild MS even in later stages of the disease, emphasizing crucial information to convey to patients throughout their journey; faculty also explore cases where disease-modifying therapies (DMTs) may not be utilized.
